Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for July 5th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, July 5th:

Fly Leasing Limited (FLY - Free Report) : This commercial aircraft leaser has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 24.8% over the last 60 days.

Fly Leasing has a price-to-earnings ratio (P/E) of 4.31, compared with 9.70 for the industry. The company possesses a Value Score of A.

Warrior Met Coal, Inc. (HCC - Free Report) : This metallurgical coal producer has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 5.5% over the last 60 days.

Warrior Met Coal has a price-to-earnings ratio (P/E) of 3.95, compared with 6.10 for the industry. The company possesses a Value Score of A.

Third Point Reinsurance Ltd. (TPRE - Free Report) : This provider of specialty property and casualty reinsurance products to insurance and reinsurance companies has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 10.9% over the last 60 days.

Third Point Reinsurance has a price-to-earnings ratio (P/E) of 3.46, compared with 17.60 for the industry. The company possesses a Value Score of B.

Uniti Group Inc. (UNIT - Free Report) : This real estate investment trust has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.8% over the last 60 days.

Uniti has a price-to-earnings ratio (P/E) of 4.15 compared with 16.60 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>